Castle Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	745	1,155	759	592	625	1,088
Market Cap Growth	34.66%	52.13%	28.33%	-5.37%	-42.55%	-34.70%
Enterprise Value	519.94	892.21	492.29	363.76	379.76	766.42
Last Close Price	24.56	38.90	26.65	21.58	23.54	42.87
PE Ratio	-	-	42.98	-	-	-
PS Ratio	2.19	3.35	2.29	2.69	4.56	11.56
PB Ratio	1.61	2.45	1.67	1.51	1.57	2.64
P/TBV Ratio	1.99	3.04	2.23	2.11	2.25	3.34
P/FCF Ratio	164.87	40.77	20.77	-	-	-
P/OCF Ratio	15.44	17.95	11.70	-	-	-
EV/Sales Ratio	1.53	2.59	1.48	1.66	2.77	8.15
EV/EBITDA Ratio	-	-	19.96	-	-	-
EV/EBIT Ratio	-	-	56.78	-	-	-
EV/FCF Ratio	115.08	31.50	13.47	-	-	-
Debt / Equity Ratio	0.07	0.07	0.05	0.04	0.03	0.02
Debt / EBITDA Ratio	-	-	1.07	-	-	-
Debt / FCF Ratio	8.13	1.30	0.72	-	-	-
Net Debt / Equity Ratio	-0.49	-0.56	-0.58	-0.58	-0.61	-0.78
Net Debt / EBITDA Ratio	12.26	128.79	-10.82	4.09	3.94	8.77
Net Debt / FCF Ratio	-49.79	-9.27	-7.30	11.83	5.19	14.31
Asset Turnover	0.60	0.62	0.67	0.49	0.30	0.21
Inventory Turnover	7.26	7.73	7.49	7.55	10.67	7.47
Quick Ratio	6.23	4.99	6.97	5.90	7.81	13.94
Current Ratio	6.75	5.26	7.29	6.20	8.09	14.21
Return on Equity (ROE)	-4.83%	-5.24%	4.31%	-14.54%	-16.56%	-11.78%
Return on Assets (ROA)	-7.46%	-6.32%	1.49%	-15.12%	-15.60%	-10.82%
Return on Invested Capital (ROIC)	-18.88%	-17.66%	4.16%	-42.92%	-58.18%	-98.53%
Return on Capital Employed (ROCE)	-6.60%	-8.63%	1.95%	-16.64%	-17.16%	-9.36%
Earnings Yield	-	-	2.33%	-	-	-
FCF Yield	0.61%	2.45%	4.81%	-	-	-
Buyback Yield / Dilution	-4.45%	0.92%	-9.15%	-2.87%	-3.65%	-32.80%
Total Shareholder Return	-4.45%	0.92%	-9.15%	-2.87%	-3.65%	-32.80%

SEC Filings: 10-K · 10-Q